Torx Software announces the launch of Torx, a new web-based platform for small molecule discovery chemistry. Torx enables chemists to work together, share ideas, manage resources and track progress in the Design-Make-Test-Analyze (DMTA) workflow.
Molecule design, review, prioritization, resource allocation and synthesis scheduling are separate parts of a complex process that can lead to productivity bottlenecks and slow the drug discovery process. Torx deploys dedicated applications within medicinal chemistry workflows to reimagine the end-to-end process and create a team-friendly, productivity-centric approach. Coupled with enabling research managers to manage synthesis resourcing and prioritization, Torx can reduce time to quality candidate selection by working through DMTA cycles faster and more efficiently.
“Torx connects the discovery process across teams in different locations,” said Dr Tim Cheeseright, CEO, Torx Softwae, “Torx provides an information rich environment for small molecule design combined with detailed scheduling and management of synthetic chemistry. Chemists can share knowledge and ideas. Project managers can track progress and resources, all from the same software platform.”
“We are delighted to launch Torx to the chemistry community bringing together key technologies from both Cresset and Elixir into a single DMTA workflow application”, said Dr Paul Faulder, CEO, Elixir Software. “This ground-breaking platform will facilitate increased efficiency of chemistry teams and their partners around the world working towards their next clinical candidate.”